Ironwood Pharmaceuticals IRWD Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Ironwood Pharmaceuticals’s reported figures.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's enterprise value?
- Ironwood Pharmaceuticals (IRWD) reported enterprise value of $564.22M in Q1 2026.
- How has Ironwood Pharmaceuticals's enterprise value changed year-over-year?
- Ironwood Pharmaceuticals's enterprise value increased by 298.2% year-over-year, from $141.68M to $564.22M.
- What is the long-term trend for Ironwood Pharmaceuticals's enterprise value?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's enterprise value has grown at a -18.3% compound annual growth rate (CAGR), from $1.49B to $545.57M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.